1. |
Vuitton DA, Zhou H, Bresson-Hadni S, et al. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology, 2003, 127 Suppl:87-107.
|
2. |
路越晴, 邓勇, 张灵强, 等. 泡型肝包虫病的临床治疗进展. 中国普外基础与临床杂志, 2016, 23(5):547-550.
|
3. |
侯玉虎, 马淑梅, 樊海宁, 等. 青海达日、班玛地区小学生肝包虫病患病情况调查. 现代预防医学, 2016, 43(13):2363-2365, 2381.
|
4. |
张昀昊, 任利, 阳丹才让, 等. 肝泡型包虫病根治性切除163例回顾性分析. 中国普通外科杂志, 2016, 25(2):257-263.
|
5. |
刘平, 李金花, 李印, 等. 包虫病病原在我国的流行现状及成因分析. 中国动物检疫, 2016, 23(1):48-51.
|
6. |
Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol, 2011, 25(2):195-206.
|
7. |
吴向未, 陈雪玲, 彭心宇, 等. Ⅰ、Ⅲ、Ⅳ型胶原在肝包虫囊肿周围人体纤维囊壁中的特异性分层表达. 中国人兽共患病学报, 2004, 20(10):876-879.
|
8. |
王俊华, 魏绪法, 张传山, 等. Ⅰ、Ⅲ、Ⅳ胶原基因在泡球蚴感染中期小鼠肝脏中的表达及意义. 中国病原生物学杂志, 2012, 7(9):653-656.
|
9. |
吴晓玲, 曾维政, 蒋明德, 等. 肝纤维化的信号转导通路. 世界华人消化杂志, 2006, 14(22):2223-2228.
|
10. |
杨艳宏, 蔡卫民, 金国梁, 等. 日本血吸虫感染兔肝肌成纤维细胞的动态变化及其意义. 中华医学杂志, 1999, 79(11):870-873.
|
11. |
Mattern J, Stammler G, Koomagi R, et al. Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. Anticancer Res, 1997, 17(17):621-624.
|
12. |
Chauchet A, Grenouillet F, Knapp J, et al. Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions. Clin Infect Dis, 2014, 59(8):1095-1104.
|
13. |
Wang J, Gottstein B. Immunoregulation in larval Echinococcus multilocularis, infection. Parasite Immunol, 2016, 38(3):182-192.
|
14. |
Zhang F, Pang N, Zhu Y, et al. CCR7lo PD-1hi, CXCR5+, CD4+, T cells are positively correlated with levels of IL-21 in active and transitional cystic echinococcosis patients. BMC Infect Dis, 2015, 15(1):1-11.
|
15. |
张梦然, 成军. 肝纤维化研究进展. 国际消化病杂志, 2014,34(6):374-379.
|
16. |
张斌. 肝纤维化的发病机理研究进展. 现代诊断与治疗, 2004, 15(6):354-359.
|
17. |
李伟道. 诊断肝纤维化、肝硬变的新进展:血清中细胞外基质成份的测定. 中国普外基础与临床杂志, 1997, 4(1):37-39.
|
18. |
王要军, 孙自勤. 肝窦内皮细胞与肝纤维化. 临床肝胆病杂志, 1996, 12(3):115-117.
|
19. |
Ryhanen L, Stenback F, Ala-Kokko L, et al. The effect of malotilate on type Ⅲ and type Ⅳ collagen, laminin and fibronectin metabolism in dimethylnitrosamine-induced liver fibrosis in the rat. J Hepatol, 1996, 24(2):238-245.
|
20. |
Nakayama Y, Takahara T, Miyabayashi C, et al. Ultrastructural localization of type Ⅳcollagen and laminin in the Disse space of rat liver with carbon tetrachloride induced fibrosis. Liver, 1991, 11(5):260-271.
|
21. |
Murawaki Y, Ikuta Y, Koda M, et al. Comparison of serum 7S fragment of type Ⅳ collagen and serum central triple-helix of type Ⅳ collagen for assessment of liver fibrosis in patients with chronic viral liver disease. J Hepatol, 1996, 24(2):148-154.
|
22. |
Tsutsumi M, Takase S, Urashima S, et al. Serum markers for hepatic fibrosis in alcoholic liver disease:which is the best marker, type Ⅲ procollagen, type Ⅳ collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase? Alcohol Clin Exp Res, 1996, 20(9):1512-1517.
|
23. |
陈光文, 宋彬. 非侵入性方法评价肝纤维化. 中国普外基础与临床杂志, 2009, 16(5):414-417.
|
24. |
Macwell PR, Flisiak R. Changes in serological biomarkers of liver funchtion and connective tissue turnover in chronic hepatitis B during lamivudine therapy. Biomarkerds, 2005, 10(6):475-484.
|
25. |
Vuitton DA, Guerret-Stocker S, Carbillet JP, et al. Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis. Z Parasitenkd, 1986, 72(1):97-104.
|
26. |
Dar FK, Alkarmi T. 泡球蚴病的免疫病理学. 国际医学寄生虫病杂志, 1998, 25(6):270-272.
|